9-137048790-G-A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_203468.3(ENTPD2):​c.1355C>T​(p.Pro452Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000349 in 1,434,450 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000035 ( 0 hom. )

Consequence

ENTPD2
NM_203468.3 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.787

Publications

1 publications found
Variant links:
Genes affected
ENTPD2 (HGNC:3364): (ectonucleoside triphosphate diphosphohydrolase 2) The protein encoded by this gene is the type 2 enzyme of the ecto-nucleoside triphosphate diphosphohydrolase family (E-NTPDase). E-NTPDases are a family of ecto-nucleosidases that hydrolyze 5'-triphosphates. This ecto-ATPase is an integral membrane protein. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.053090006).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ENTPD2NM_203468.3 linkc.1355C>T p.Pro452Leu missense_variant Exon 9 of 9 ENST00000355097.7 NP_982293.1 Q9Y5L3-1
ENTPD2NM_001246.4 linkc.1286C>T p.Pro429Leu missense_variant Exon 9 of 9 NP_001237.1 Q9Y5L3-2
ENTPD2XM_011519212.3 linkc.1046C>T p.Pro349Leu missense_variant Exon 8 of 8 XP_011517514.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENTPD2ENST00000355097.7 linkc.1355C>T p.Pro452Leu missense_variant Exon 9 of 9 1 NM_203468.3 ENSP00000347213.2 Q9Y5L3-1
ENTPD2ENST00000312665.7 linkc.1286C>T p.Pro429Leu missense_variant Exon 9 of 9 1 ENSP00000312494.5 Q9Y5L3-2
ENTPD2ENST00000460614.1 linkn.744C>T non_coding_transcript_exon_variant Exon 2 of 2 1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
216958
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000349
AC:
5
AN:
1434450
Hom.:
0
Cov.:
39
AF XY:
0.00000422
AC XY:
3
AN XY:
710806
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33076
American (AMR)
AF:
0.00
AC:
0
AN:
42962
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24336
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39244
South Asian (SAS)
AF:
0.00
AC:
0
AN:
82082
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50062
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5660
European-Non Finnish (NFE)
AF:
0.00000455
AC:
5
AN:
1097856
Other (OTH)
AF:
0.00
AC:
0
AN:
59172
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 26, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1355C>T (p.P452L) alteration is located in exon 9 (coding exon 9) of the ENTPD2 gene. This alteration results from a C to T substitution at nucleotide position 1355, causing the proline (P) at amino acid position 452 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.71
CADD
Benign
18
DANN
Benign
0.95
DEOGEN2
Benign
0.048
T;.
Eigen
Benign
-0.78
Eigen_PC
Benign
-0.70
FATHMM_MKL
Benign
0.12
N
LIST_S2
Benign
0.69
T;T
M_CAP
Benign
0.025
T
MetaRNN
Benign
0.053
T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
0.46
N;.
PhyloP100
-0.79
PrimateAI
Benign
0.47
T
PROVEAN
Benign
-1.8
N;N
REVEL
Benign
0.047
Sift
Benign
0.34
T;T
Sift4G
Benign
0.29
T;T
Polyphen
0.0050
B;B
Vest4
0.083
MutPred
0.48
Loss of disorder (P = 0.0149);.;
MVP
0.36
MPC
0.057
ClinPred
0.082
T
GERP RS
0.99
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.052
gMVP
0.50
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1461483025; hg19: chr9-139943242; API